NCT01932554 Abciximab (ReoPro) as a Therapeutic Intervention for Sickle Cell Vaso-Occlusive Pain Crisis Status WITHDRAWN Phase PHASE2
NCT01925001 Phase 2 Study of MP4CO to Treat Vaso-occlusive Sickle Crisis Status WITHDRAWN Phase PHASE2
NCT01917708 Bone Marrow Transplant With Abatacept for Non-Malignant Diseases Status COMPLETED Phase PHASE1
NCT01911871 Multicenter Observational Study on Myocardial Iron Overload in 3 Multitransfused Populations Status COMPLETED Phase N/A
NCT01895998 Quantifying the Presence of Lung Disease and Pulmonary Hypertension in Children With Sickle Cell Disease Status COMPLETED Phase PHASE1
NCT01895361 Study to Assess Safety and Impact of SelG1 With or Without Hydroxyurea Therapy in Sickle Cell Disease Patients With Pain Crises Status COMPLETED Phase PHASE2
NCT01888614 Exhaled Carbon Monoxide as a Marker of Hemolysis in Sickle Cell Disease- an Exploratory Study Status WITHDRAWN Phase N/A
NCT01850108 Non-Myeloablative Conditioning and Bone Marrow Transplantation Status ACTIVE_NOT_RECRUITING Phase NA
NCT01848925 Study of SANGUINATE™ Versus Hydroxyurea in Sickle Cell Disease (SCD) Patients Status COMPLETED Phase PHASE1
NCT01835496 Absorption, Metabolism, and Excretion of a Single Dose of Ferriprox® in Patients With Sickle Cell Disease Status COMPLETED Phase PHASE1
NCT01800526 A Pilot Study of N-acetylcysteine in Patients With Sickle Cell Disease Status COMPLETED Phase PHASE1/PHASE2
NCT01794000 A Study of Prasugrel in Pediatric Participants With Sickle Cell Disease (SCD) Status TERMINATED Phase PHASE3